Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07285707 · ClinicalTrials.gov registry record · NA

Acupuncture and Chinese Herbal Medicine for Long COVID

A NA study of Long COVID, sponsored by Southern California University of Health Sciences.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07285707: Recruiting NA study of Long COVID, sponsored by Southern California University of Health Sciences.

NCT07285707 is a NA study of Long COVID that is actively recruiting participants, run by Southern California University of Health Sciences. The registered enrollment target is 10 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07285707, a NA study of Long COVID, is actively recruiting participants, sponsored by Southern California University of Health Sciences.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

List of the Hypothesis: Primary hypothesis: A flexible acupuncture and Chinese herbal medicine protocol will be feasible, acceptable, and useful for the treatment of long COVID. Secondary hypothesis: Long COVID patients receiving acupuncture treatment or acupuncture treatment and Chinese herbal supplements over an 8-week period will see improvements in their symptoms, function, and quality of life measurements. Specific Aims of This Research (Purpose of the study): To study the feasibility, acceptability and utility of an acupuncture and Chinese herbal supplement treatment protocol for patients with long COVID and preliminarily assess the effects of treatment. Currently Available Research on This Subject: Studies indicate that acupuncture can effectively treat symptoms that are similar to those often seen in long COVID patients. Additionally, recent studies and clinical evidence suggest that there is substantial potential for acupuncture in the treatment of long COVID. Acupuncture may be beneficial because it can address many symptoms simultaneously with a single intervention, whereas symptom clusters can be difficult to manage with pharmaceuticals due to the need for multiple pharmaceutical agents. Summary of the research protocol/methodology: Five patients will receive acupuncture treatment, and five patients will receive acupuncture and Chinese herbal medicine. Each participant will receive 16 acupuncture treatments over the course of eight weeks (i.e., twice per week). Each treatment session will last for 30 minutes. Follow-up will occur at 12 weeks (i.e., four weeks after the final treatment session). Significance of this research to the health and welfare of general public: There is currently not a single, specific treatment for long COVID. If acupuncture treatment alone and/or acupuncture and Chinese herbal medicine combined are feasible, acceptable, and efficacious in the improvement of long COVID symptoms, it will offer patients additional treatme

Primary Outcome

Feasibility will be measured through a feasibility assessment questionnaire which will evaluate recruitment, retention, and adherence metrics across the 12-week intervention and the final follow-up. Feasibility indicators will be summarized as proportions and descriptive statistics to evaluate the practicality of the study procedures and protocol implementation.

Conditions Studied

Interventions

  • PROCEDURE Acupuncture

Study Locations (1)

California

  • SCUHS - Whittier

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-09-10
Est. Completion 2026-12-31
Phase NA

What NCT07285707 shows while recruiting

NCT07285707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT07285707 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07285707 about?

NCT07285707 is a clinical study titled "Acupuncture and Chinese Herbal Medicine for Long COVID". List of the Hypothesis: Primary hypothesis: A flexible acupuncture and Chinese herbal medicine protocol will be feasible, acceptable, and useful for the treatment of long COVID. Secondary hypothesis: Long COVID patients receiving acupuncture treatment or acupuncture treatment and Chinese herbal su...

What is the current status of trial NCT07285707?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-09-10. Estimated completion is 2026-12-31.

What conditions does trial NCT07285707 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT07285707?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT07285707?

This trial is sponsored by Southern California University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07285707 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07285707's enrollment target sits among peer trials

10 51st of 50 the lowest of 50 other Long COVID trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07285707, the US trial registry maintained by the National Library of Medicine. NCT07285707 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.